Your browser doesn't support javascript.
loading
The impact of transfused blood products on deceased donor HLA typing.
Jacob, Reuben P; Dean, Christina L; Krummey, Scott M; Shah, Zuleikha; Sutherland, Nathaniel; Orear, Casey; Gebel, Howard M; Bray, Robert A; Sullivan, Harold C.
Afiliación
  • Jacob RP; Department of Pathology, Stanford University, Stanford, CA, United States.
  • Dean CL; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.
  • Krummey SM; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.
  • Shah Z; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.
  • Sutherland N; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.
  • Orear C; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.
  • Gebel HM; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.
  • Bray RA; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.
  • Sullivan HC; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States. Electronic address: hcsulli@emory.edu.
Hum Immunol ; 80(12): 976-982, 2019 Dec.
Article en En | MEDLINE | ID: mdl-31627937
ABSTRACT
Accurate deceased donor HLA typing assumes that the blood sample tested contains only DNA from the organ donor. Prior to procurement, many organ donors are transfused at least one unit of red blood cells (RBC). Non-organ donor DNA acquired from transfusions may result in incorrect and/or ambiguous HLA typing. To address this question, we investigated the impact of RBC transfusion on organ donor HLA typing by using different in vitro transfusion models leukoreduced (LR) and non-LR RBCs. Various quantities of LR and non-LR RBCs were added to normal peripheral blood and HLA typing was performed by real time PCR. Our results show that HLA typing of deceased donors can be impacted dependent upon the type and quantity of transfused RBCs. Importantly, if LR RBCs are given, HLA typing is unlikely to be affected, precluding the need to delay typing and obtain an alternative source of donor DNA.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prueba de Histocompatibilidad / Transfusión de Eritrocitos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Hum Immunol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prueba de Histocompatibilidad / Transfusión de Eritrocitos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Hum Immunol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos